Strategies to improve posttransplant immunity - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 135

[65] Maki K, Sunaga S, Komagata Y, Kodaira Y, Mabuchi A, Karasuyama H, et al. Inter-
leukin 7 receptor-deficient mice lack gammadelta T cells. Proc Natl Acad Sci USA
1996;93(14):7172-7.
[66] Boise LH, Minn AJ, June CH, Lindsten T, Thompson CB. Growth factors can enhance
lymphocyte survival without committing the cell to undergo cell division. Proc Natl
Acad Sci USA 1995;92(12):5491-5.
[67] Gringhuis SI, de Leij LF, Verschuren EW, Borger P, Vellenga E. Interleukin-7 upregulates
the interleukin-2-gene expression in activated human T lymphocytes at the transcrip-
tional level by enhancing the DNA binding activities of both nuclear factor of activated
T cells and activator protein-1. Blood 1997;90(7):2690-700.
[68] Chazen GD, Pereira GM, LeGros G, Gillis S, Shevach EM. Interleukin 7 is a T-cell growth
factor. Proc Natl Acad Sci USA 1989;86(15):5923-7.
[69] Costello R, Brailly H, Mallet F, Mawas C, Olive D. Interleukin-7 is a potent co-stim-
ulus of the adhesion pathway involving CD2 and CD28 molecules. Immunology
1993;80(3):451-7.
[70] Mehrotra PT, Grant AJ, Siegel JP. Synergistic effects of IL-7 and IL-12 on human T cell
activation. J Immunol 1995;154(10):5093-102.
[71] Lynch DH, Namen AE, Miller RE. In vivo evaluation of the effects of interleukins 2, 4
and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lympho-
cytes. Eur J Immunol 1991;21(12):2977-85.
[72] van der Vliet HJ, Nishi N, Koezuka Y, von Blomberg BM, van den Eertwegh AJ, Porcelli
SA, et al. Potent expansion of human natural killer T cells using alpha-galactosylce-
ramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence
of IL-7 and IL-15. J Immunol Methods 2001;247(1-2):61-72.
[73] Faltynek CR, Wang S, Miller D, Young E, Tiberio L, Kross K, et al. Administration of human
recombinant IL-7 to normal and irradiated mice increases the numbers of lymphocytes
and some immature cells of the myeloid lineage. J Immunol 1992;149(4):1276-82.
[74] Boerman OC, Gregorio TA, Grzegorzewski KJ, Faltynek CR, Kenny JJ, Wiltrout RH, et al.
Recombinant human IL-7 administration in mice affects colony-forming units-spleen
and lymphoid precursor cell localization and accelerates engraftment of bone marrow
transplants. J Leukoc Biol 1995;58(2):151-8.
[75] Bolotin E, Smogorzewska M, Smith S, Widmer M, Weinberg K. Enhancement
of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood
1996;88(5):1887-94. Epub 1996/09/01.
[76] Fry TJ, Christensen BL, Komschlies KL, Gress RE, Mackall CL. Interleukin-7 restores im-
munity in athymic T-cell-depleted hosts. Blood 2001;97(6):1525-33.
[77] Mackall CL, Fry TJ, Bare C, Morgan P, Galbraith A, Gress RE. IL-7 increases both thymic-
dependent and thymic-independent T-cell regeneration after bone marrow transplan-
tation. Blood 2001;97(5):1491-7.
[78] Broers AE, Posthumus-van Sluijs SJ, Spits H, van der Holt B, Lowenberg B, Braakman E,
et al. Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone
marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic
emigrants. Blood 2003;102(4):1534-40.
[79] Andre-Schmutz I, Bonhomme D, Yates F, Malassis M, Selz F, Fischer A, et al. IL-7 effect
on immunological reconstitution after HSCT depends on MHC incompatibility. Br J
Haematol 2004;126(6):844-51.
[80] Alpdogan O, Schmaltz C, Muriglan SJ, Kappel BJ, Perales MA, Rotolo JA, et al. Ad-
ministration of interleukin-7 after allogeneic bone marrow transplantation im-
proves immune reconstitution without aggravating graft-versus-host disease. Blood
2001;98(7):2256-65. Epub 2001/09/25.
[81] Alpdogan O, Muriglan SJ, Eng JM, Willis LM, Greenberg AS, Kappel BJ, et al. IL-7
enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell
transplantation. J Clin Invest 2003;112(7):1095-107.
[82] Sinha ML, Fry TJ, Fowler DH, Miller G, Mackall CL. Interleukin 7 worsens graft-versus-
host disease. Blood 2002;100(7):2642-9.
[83] Gendelman M, Hecht T, Logan B, Vodanovic-Jankovic S, Komorowski R, Drobyski WR.
Host conditioning is a primary determinant in modulating the effect of IL-7 on murine
graft-versus-host disease. J Immunol 2004;172(5):3328-36.
[84] Storek J, Gillespy 3rd T, Lu H, Joseph A, Dawson MA, Gough M, et al. Interleukin-7
improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in mon-
keys. Blood 2003;101(10):4209-18.
[85] Lu H, Zhao Z, Kalina T, Gillespy 3rd T, Liggitt D, Andrews RG, et al. Interleukin-7 im-
proves reconstitution of antiviral CD4 T cells. Clin Immunol 2005;114(1):30-41.
[86] Rosenberg SA, Sportes C, Ahmadzadeh M, Fry TJ, Ngo LT, Schwarz SL, et al. IL-7
administration to humans leads to expansion of CD8 + and CD4 + cells but a relative
decrease of CD4 + T-regulatory cells. J Immunother 2006;29(3):313-9.

137